The DOI matches its Crossref record.
Interferons as macrophage-activating factors. III. Preferential effects of interferon- gamma on the interleukin 1 secretory potential of fresh or aged human monocytes.
Abstract
Human peripheral blood adherent leukocytes incubated with interferon (IFN) of three different species (alpha, beta, or gamma) show an enhanced potential of IL 1 synthesis and secretion that can be revealed by a second signal provided by endotoxins or Poly IC. We have shown that recombinant IFN-gamma, compared with recombinant IFN-alpha or purified IFN-beta, has preferential effects on IL 1 secretion in fresh monocyte cultures. We have observed a progressive and profound loss of the ability of adherent cell cultures to secrete IL 1 upon aging for 4 to 12 days in vitro. IFN-gamma was found to be more efficient than IFN-alpha or -beta at maintaining (when added at the onset of the cultures) or reversing the loss (when added on the fourth day of culture) of the IL 1 secretory function. These observations suggest that the secretion of IFN-gamma during the course of immune responses may have a critical role in feeding back the cascade of interleukins in a loop of amplification, and may thereby regulate macrophage-T lymphocyte interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
There is more than one interleukin 1
Oppenheim, J. J., Kovacs, E. J., Matsushima, K., & Durum, S. K. (1986) · Immunology Today · doi:10.1016/0167-5699(86)90124-6 · Cited by 1,203
Philip, R., & Epstein, L. B. (1986) · Nature · doi:10.1038/323086a0 · Cited by 767
Poole, S., Singhrao, S. K., Kesavalu, L., Curtis, M. A., & Crean, S. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-121918 · Cited by 598
Cavaillon, J. M. (1994) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(94)90005-1 · Cited by 454
te Velde, A., Huijbens, R., Heije, K., de Vries, J., & Figdor, C. (1990) · Blood · doi:10.1182/blood.v76.7.1392.1392 · Cited by 449
Interferon-γ: Biology and Role in Pathogenesis
Billiau, A. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60428-9 · Cited by 433
Interferon-Gamma, the Activated Macrophage, and Host Defense Against Microbial Challenge
MURRAY, H. W. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-4-595 · Cited by 422
Induction of Macrophage Tumoricidal Activity by Granulocyte-Macrophage Colony-Stimulating Factor
Grabstein, K. H., Urdal, D. L., Tushinski, R. J., Mochizuki, D. Y., Price, V. L., Cantrell, M. A., Gillis, S., & Conlon, P. J. (1986) · Science · doi:10.1126/science.3083507 · Cited by 412
A potential role of macrophage activation in the treatment of cancer
Klimp, A. H., de Vries, E. G. E., Scherphof, G. L., & Daemen, T. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00203-7 · Cited by 360
Interleukin 1: the first interleukin
di Giovine, F. S., & Duff, G. W. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90005-t · Cited by 338
Taubman, M. A., & Kawai, T. (2001) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411010120020301 · Cited by 296
Porphyromonas gingivalis Periodontal Infection and Its Putative Links with Alzheimer’s Disease
Singhrao, S. K., Harding, A., Poole, S., Kesavalu, L., & Crean, S. (2015) · Mediators of Inflammation · doi:10.1155/2015/137357 · Cited by 195
Tumor necrosis factor receptor fragment attenuates interferon-γ-induced non-REM sleep in rabbits
Kubota, T., Majde, J. A., Brown, R. A., & Krueger, J. M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00382-4 · Cited by 32
Metadata
- Authors
- Arenzana-Seisdedos, F., Virelizier, J. L., & Fiers, W.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1985-04-01
- Volume
- 134
- Issue
- 4
- Pages
- 2444-2448
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1957435208
- Cited by
- 217
- References
- 0
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.